Sch 56396: A new c-fos proto-oncogene inhibitor produced by the fungus Tolypocladium sp.

Journal of Antibiotics

Volumn 50, Issue 12, 1997, Pages 1061-1063

  Chu, M ^a   Truumees, I ^a   Mierzwa, R ^a   Patel, M ^a   Puar, M S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C FOS; PROTEIN INHIBITOR; SCH 56396; UNCLASSIFIED DRUG; PIPERAZINE DERIVATIVE;

CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; FERMENTATION; FUNGUS; GENETIC TRANSCRIPTION; NONHUMAN; ONCOGENE C FOS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SHORT SURVEY; ARTICLE; ASCOMYCETES; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOGENE;

GENES, FOS; HYPOCREALES; MAGNETIC RESONANCE SPECTROSCOPY; PIPERAZINES;

EID: 0031440561     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.1061     Document Type: Short Survey

References (10)

1. CHU, M.; I. TRUUMEES, M. L. ROTHOFSKY, M. G. PATEL, F. GENTILE, P. R. DAS, M. S. PUAR & S. L. LIN: Inhibition of c-fos proto-oncogene induction by Sch 52900 and Sch 52901, novel diketopiperazines produced by Gliocladium sp. J. Antibiotics 48: 1440-1445, 1995
2. GREENBERG, M. E. & E. B. ZIFF: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (London) 311: 433-438, 1984
3. FISCH, T. M.; R. PRYWES & R. G. ROEDER: c-fos sequences necessary for basal expression and induction by spidermal growth factor, 12-O-tetradecanoyl phorbol-1-acetate, and the calcium iopophore. Mol. Cell Biol. 7: 3490-3502, 1987
4. HAYES, T. E.; A. M. KITCHEN & B. H. COCHRAN: Inducible binding of a factor to the c-fos regulatory region. Proc. Natl. Acad. Sci. (USA) 84: 1272-1276, 1987
5. FUJII, M. D.; D. SHALLOWAY & I. M. VERMA: Gene regulation by tyrosine kinase: src protein activates various promoters, including c-fos. Mol. Cell Biol. 9: 2493-2499, 1989
6. JAMAL, S. & E. ZIFF: Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals. Nature 344: 463-466, 1990
7. GETMAN, A.; C. WASYLYK & B. WASYLYK: Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter. Mol. Cell Biol. 11: 5381-5387, 1991
8. O'HARA, B. M.; H. P. KLINGER, T. CURRAN, Y.-D. ZHANG & D. G. BLAIR: Levels of fos, ets2, and myb protooncogene RNAs correlate with segregation of chromosone 11 of normal cells and with suppression of tumorigenicity in human cell hybrids. Mol. Cell Biol. 7: 2941-2946, 1987
9. For the MTT assay standard protocol: TANIGUCHI, Y.; K. SUZUKI, M. NAKAJIMA, Y. MIWA, Y. YAMADA, M. SATOH, M. TAKEYOSHI, Y. AKIE & M. MORIYASU: Inter-laboratory validation study of the Skin2 Dermal Model ZK1100 and MTT cytotoxicity assay kits. J. Toxicol. Sci. 19: 37-44, 1994
10. FANNING, J.; W. C. BIDDLE, M. GOLDROSEN, K. CRICKARD, U. CRICKARD, M. S. PIVER & K. A. FOON: Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay. Gynecol. Oncol. 39: 119-122, 1990